HSIC vs. ABBV
HSIC (Henry Schein, Inc.) and ABBV (AbbVie Inc.) are both stocks. Both are in the Healthcare sector — HSIC in Medical Distribution, ABBV in Drug Manufacturers - General. Over the past 10 years, HSIC returned 1.80%/yr vs 19.47%/yr for ABBV. At a 0.36 correlation, their price movements are largely independent.
Performance
HSIC vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HSIC achieves a 5.98% return, which is significantly higher than ABBV's 4.43% return. Over the past 10 years, HSIC has underperformed ABBV with an annualized return of 1.80%, while ABBV has yielded a comparatively higher 19.47% annualized return.
HSIC
- 1D
- 1.82%
- 1M
- 7.94%
- YTD
- 5.98%
- 6M
- 4.71%
- 1Y
- 11.42%
- 3Y*
- 0.50%
- 5Y*
- 1.29%
- 10Y*
- 1.80%
ABBV
- 1D
- 2.07%
- 1M
- 8.84%
- YTD
- 4.43%
- 6M
- 4.29%
- 1Y
- 31.92%
- 3Y*
- 24.36%
- 5Y*
- 19.80%
- 10Y*
- 19.47%
HSIC vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HSIC Henry Schein, Inc. | 5.98% | 9.22% | -8.60% | -5.21% | 3.02% | 15.96% | 0.21% | 8.34% | 12.36% | -7.88% |
ABBV AbbVie Inc. | 4.43% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between HSIC and ABBV is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.36 |
The correlation between HSIC and ABBV shifts across timeframes, from 0.19 (1 year) to 0.36 (all time), reflecting how their relationship changes across market environments.
Fundamentals
HSIC:
$9.30B
ABBV:
$416.46B
HSIC:
$3.30
ABBV:
$2.05
HSIC:
24.24
ABBV:
114.38
HSIC:
0.72
ABBV:
6.63
HSIC:
2.85
ABBV:
15.14
HSIC:
$13.38B
ABBV:
$62.82B
HSIC:
$3.91B
ABBV:
$46.15B
HSIC:
$940.00M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HSIC vs. ABBV — Risk / Return Rank
HSIC
ABBV
HSIC vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Henry Schein, Inc. (HSIC) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HSIC | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.86 | ||
| Sortino ratioReturn per unit of downside risk | -1.08 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.24 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | 1.85 | -1.19 |
| Martin ratioReturn relative to average drawdown | 1.37 | 4.11 | -2.74 |
Loading charts...
Drawdowns
HSIC vs. ABBV - Drawdown Comparison
The maximum HSIC drawdown since its inception was -78.49%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for HSIC and ABBV.
Loading charts...
Drawdown Indicators
| HSIC | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.49% | -45.09% | -33.40% |
Max Drawdown (1Y)Largest decline over 1 year | -17.23% | -17.32% | +0.09% |
Max Drawdown (3Y)Largest decline over 3 years | -24.59% | -20.74% | -3.85% |
Max Drawdown (5Y)Largest decline over 5 years | -32.70% | -21.92% | -10.78% |
Max Drawdown (10Y)Largest decline over 10 years | -41.42% | -45.09% | +3.67% |
Current DrawdownCurrent decline from peak | -12.90% | -1.66% | -11.24% |
Average DrawdownAverage peak-to-trough decline | -15.25% | -10.70% | -4.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.34% | 7.78% | +0.56% |
Volatility
HSIC vs. ABBV - Volatility Comparison
The current volatility for Henry Schein, Inc. (HSIC) is 5.53%, while AbbVie Inc. (ABBV) has a volatility of 9.26%. This indicates that HSIC experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HSIC | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | 9.26% | -3.73% |
Volatility (6M)Calculated over the trailing 6-month period | 17.95% | 19.11% | -1.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.57% | 25.23% | +2.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.42% | 23.12% | +2.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.54% | 25.83% | +1.71% |
Dividends
HSIC vs. ABBV - Dividend Comparison
HSIC has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.87%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.87% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
HSIC Henry Schein, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
HSIC vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Henry Schein, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HSIC vs. ABBV - Profitability Comparison
HSIC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Henry Schein, Inc. reported a gross profit of 1.00B and revenue of 3.37B. Therefore, the gross margin over that period was 29.8%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
HSIC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Henry Schein, Inc. reported an operating income of 194.00M and revenue of 3.37B, resulting in an operating margin of 5.8%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
HSIC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Henry Schein, Inc. reported a net income of 107.00M and revenue of 3.37B, resulting in a net margin of 3.2%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
HSIC and ABBV have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABBV has higher volatility (9.26%) compared to HSIC (5.53%). In terms of maximum drawdown, HSIC dropped -78.49% vs ABBV's -45.09%.
ABBV currently has the higher Sharpe Ratio (1.27 vs 0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HSIC and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer